This newest twist in the Lykos Therapeutics saga threatens An important overhaul of the corporate’s system and direction, with Musk ally and billionaire investor Antonio Gracias showing up to wish to consider the organization back towards its nonprofit drug growth roots and a far more Doblinite philosophy.The foodstuff allergy application was fil